It is generally accepted that full and partial agonists interact with the same receptors according to the classical receptor mechanisms. We have modified the drug receptor mechanisms of M
3-, α
1- and β-receptors. Among the muscarinic receptors, there are two subtypes of M
3-cholinoceptors, propylbenzilylcholine mustard (PrBCM)-sensitive receptors and (PrBCM)-resistant ones. Full agonists contract the guinea pig ileum through both types of cholinoceptors, while the partial agonists produce contractions through only the PrBCM-sensitive receptors. Two subtypes of α
1-adrenoceptors, α
1A and α
1B, were demonstrated in some arteries. Full agonists contracted the rabbit aorta through both the α
1A- and α
1B-adrenoceptors, while the partial agonists mediated contraction through only the α
1A-adrenoceptors. β-Chloroethylamines (PrBCM and chloroethylclonidine) can discriminate the subtype of M
3 or α
1-receptors in the presence of GTP. β-Adrenoceptors have two different types of binding sites, high and low affinity sites. The competitive antagonistic effect of the partial agonist is due to their ability to compete with the full agonists for the high affinity site, while the partial agonists interact with the low affinity site to induce the β-adrenergic effect. A regional difference in α
1-adrenoceptor mechanisms was discussed. The potency of norepinephrine in veins is related to α
1-adrenoceptor densities. In contrast, the potency of norepinephrine is linearly related to the agonist dissociation constant. This discrepancy suggests a qualitative difference between α
1-adrenoceptor mechanisms in the veins and arteries.
抄録全体を表示